Blog

Japan approves first trials of stem cell-based heart treatment – Nikkei Asian Review


Nikkei Asian Review

Japan approves first trials of stem cell-based heart treatment
Nikkei Asian Review
TOKYO — Japan is set to host the world's first clinical trials involving the use of induced pluripotent stem (iPS) cells to treat heart failure. A special health ministry panel on Wednesday gave Osaka University the green light to carry out the study
Japan OKs first clinical study of iPS cell-based heart treatmentThe Japan Times



all 5 news articles »

2018-05-16 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.